QualifyHQ Logo

Enso

ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.

Opgericht

2014

Omzet

$2.5M - $5.0M

Financiering

$108.8M

Bekijk vergelijkbare bedrijven

Qualify this Company in

minutes

Terwijl andere tools tijd verspillen, helpen wij je om beter passende bedrijven in enkele minuten te kwalificeren. Zo blijft je pijplijn gezond, je team productief en sluit je deals sneller.

Start free trial

Start je 7-daagse gratis proefperiode